摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-methyl-2,3,4-trimethoxyphenethylamine | 32042-11-8

中文名称
——
中文别名
——
英文名称
N-methyl-2,3,4-trimethoxyphenethylamine
英文别名
N-Methyl-2,3,4-trimethoxyphenethylamin;Methyl[2-(2,3,4-trimethoxyphenyl)ethyl]amine;N-methyl-2-(2,3,4-trimethoxyphenyl)ethanamine
N-methyl-2,3,4-trimethoxyphenethylamine化学式
CAS
32042-11-8
化学式
C12H19NO3
mdl
——
分子量
225.288
InChiKey
AAFDMAAXSJVSCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    305.8±37.0 °C(Predicted)
  • 密度:
    1.025±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    39.7
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-methyl-2,3,4-trimethoxyphenethylamine溶剂黄146 、 sodium nitrite 作用下, 以 为溶剂, 生成 N-methyl-N-[2-(2,3,4-trimethoxyphenyl)ethyl]nitrous amide
    参考文献:
    名称:
    Synthesis, in Vitro Activity, and Three-Dimensional Quantitative Structure−Activity Relationship of Novel Hydrazine Inhibitors of Human Vascular Adhesion Protein-1
    摘要:
    Vascular adhesion protein-1 (VAP-1) belongs to the semicarbazide-sensitive amine oxidases (SSAOs) that convert amines into aldehydes. SSAOs are distinct from the mammalian monoamine oxidases (MAOs), but their substrate specificities are partly overlapping. VAP-1 has been proposed as a target for anti-inflammatory drug therapy because of its role in leukocyte adhesion to endothelium. Here, we describe the synthesis and in vitro activities of novel series of VAP-1 selective inhibitors. In addition, the molecular dynamics simulations performed for VAP-1 reveal that the movements of Met211, Ser496, and especially Leu469 can enlarge the ligand-binding pocket, allowing larger ligands than those seen in the crystal structures to bind. Combining the data from molecular dynamics simulations, docking, and in vitro measurements, the three-dimensional quantitative structure-activity relationship (3D QSAR) models for VAP-1 (q(LOO)(2): 0.636; r(2:) 0.828) and MAOs (q(LOO)(2): 0.749, r(2): 0.840) were built and employed in the development of selective VAP-1 inhibitors.
    DOI:
    10.1021/jm100337z
  • 作为产物:
    参考文献:
    名称:
    杂环化合物合成的研究。零件CCCLXXXV。1-(2-氨基苄基)-和1-(2-氨基苯乙基)-1,2,3,4-四氢异喹啉的Pschorr反应(总合成thalicsimidine)
    摘要:
    为了获得在8a-和2'-位之间偶联的二烯酮,1-(2-氨基-4,5-二甲氧基苄基)-1,2,3,4-四氢-6,8-二甲氧基-2-甲基异喹啉( IIIa)和相应的5,6,7-三甲氧基-(IIIb)和6-羟基-7-甲氧基-(IIIc)衍生物进行Pschorr反应。化合物(IIIb)得到thalicsimidine(XIXa);化合物(IIIc)得到3-硝基predicentrine(XIXb)和(2-羟基苄基)异喹啉(IIIj),以及正常产物(predicentrine)(XIXc)和二酚型化合物(Ib),收率很低。但是,1-(2-氨基-3,4,5-三甲氧基苯乙基)-(IIId)和1-(2-氨基-4-苄氧基-3,5-二甲氧基苯乙基)-1,2,3,4的Pschorr反应-四氢-6,7-二甲氧基-2-甲基异喹啉(IIIn)给出异常产物1',2',3',4'-四氢-5,6,6',7,7'-五甲氧基-2'-甲基螺[indan-1,
    DOI:
    10.1039/j39710001032
点击查看最新优质反应信息

文献信息

  • Novel calcium antagonists. Synthesis and structure-activity relationship studies of benzothiazoline derivatives
    作者:Koji Yamamoto、Masanobu Fujita、Keizo Tabashi、Yoichi Kawashima、Eishin Kato、Masayuki Oya、Tadashi Iso、Junichi Iwao
    DOI:10.1021/jm00400a006
    日期:1988.5
    A series of novel compounds having a benzothiazoline skeleton was studied for their structure-activity relationship (SAR) with respect to Ca2+ antagonistic activity. As test compounds, analogues of 3-acyl-2-arylbenzothiazolines (3) were synthesized. Benzothiazoline derivatives (3) exerted higher Ca2+ antagonistic activity than the corresponding thiazolidine derivatives (2). Effects of substituents
    研究了一系列具有苯并噻唑啉骨架的新型化合物的相对于Ca2 +拮抗活性的结构活性关系(SAR)。作为测试化合物,合成了3-酰基-2-芳基苯并噻唑啉的类似物(3)。苯并噻唑啉衍生物(3)比相应的噻唑烷衍生物(2)具有更高的Ca2 +拮抗活性。研究了取代基R1-R4,氨基烷氧基和R2的取代位置以及亚甲基链的长度对生物活性的影响。化合物4 [3-乙酰基-2- [5-甲氧基-2- [4- [N-甲基-N-(3,4,5-三甲氧基苯乙基)氨基]丁氧基]苯基]苯并噻唑啉盐酸盐]显示出有效的Ca2 +拮抗活性体外对Langendorff灌注兔心脏中Na +向内快速通道和Ca2 +向内缓慢通道的双重抑制。
  • YAMAMOTO, KOJI;FUJITA, MASANOBU;TABASHI, KEIZO;KAWASHIMA, YOICHI;KATO, EI+, J. MED. CHEM., 31,(1988) N 5, 919-935
    作者:YAMAMOTO, KOJI、FUJITA, MASANOBU、TABASHI, KEIZO、KAWASHIMA, YOICHI、KATO, EI+
    DOI:——
    日期:——
  • Synthesis, in Vitro Activity, and Three-Dimensional Quantitative Structure−Activity Relationship of Novel Hydrazine Inhibitors of Human Vascular Adhesion Protein-1
    作者:Elisa M. Nurminen、Marjo Pihlavisto、László Lázár、Zsolt Szakonyi、Ulla Pentikäinen、Ferenc Fülöp、Olli T. Pentikäinen
    DOI:10.1021/jm100337z
    日期:2010.9.9
    Vascular adhesion protein-1 (VAP-1) belongs to the semicarbazide-sensitive amine oxidases (SSAOs) that convert amines into aldehydes. SSAOs are distinct from the mammalian monoamine oxidases (MAOs), but their substrate specificities are partly overlapping. VAP-1 has been proposed as a target for anti-inflammatory drug therapy because of its role in leukocyte adhesion to endothelium. Here, we describe the synthesis and in vitro activities of novel series of VAP-1 selective inhibitors. In addition, the molecular dynamics simulations performed for VAP-1 reveal that the movements of Met211, Ser496, and especially Leu469 can enlarge the ligand-binding pocket, allowing larger ligands than those seen in the crystal structures to bind. Combining the data from molecular dynamics simulations, docking, and in vitro measurements, the three-dimensional quantitative structure-activity relationship (3D QSAR) models for VAP-1 (q(LOO)(2): 0.636; r(2:) 0.828) and MAOs (q(LOO)(2): 0.749, r(2): 0.840) were built and employed in the development of selective VAP-1 inhibitors.
  • Studies on the syntheses of heterocyclic compounds. Part CCCLXXXV. Pschorr reactions of 1-(2-aminobenzyl)- and 1-(2-aminophenethyl)-1,2,3,4-tetrahydroisoquinolines (total synthesis of thalicsimidine)
    作者:T. Kametani、K. Takahashi、T. Sugahara、M. Koizumi、K. Fukumoto
    DOI:10.1039/j39710001032
    日期:——
    7-trimethoxy-(IIIb) and 6-hydroxy-7-methoxy-(IIIc) derivatives were subjected to the Pschorr reaction. Compound (IIIb) afforded thalicsimidine (XIXa); compound (IIIc) gave 3-nitropredicentrine (XIXb) and the (2-hydroxybenzyl)isoquinoline (IIIj), together with the normal product (predicentrine)(XIXc) and the diosphenol-type compound (Ib) in poor yield. However, Pschorr reactions of 1-(2-amino-3,4,5-trimethoxyphenethyl)-(IIId)
    为了获得在8a-和2'-位之间偶联的二烯酮,1-(2-氨基-4,5-二甲氧基苄基)-1,2,3,4-四氢-6,8-二甲氧基-2-甲基异喹啉( IIIa)和相应的5,6,7-三甲氧基-(IIIb)和6-羟基-7-甲氧基-(IIIc)衍生物进行Pschorr反应。化合物(IIIb)得到thalicsimidine(XIXa);化合物(IIIc)得到3-硝基predicentrine(XIXb)和(2-羟基苄基)异喹啉(IIIj),以及正常产物(predicentrine)(XIXc)和二酚型化合物(Ib),收率很低。但是,1-(2-氨基-3,4,5-三甲氧基苯乙基)-(IIId)和1-(2-氨基-4-苄氧基-3,5-二甲氧基苯乙基)-1,2,3,4的Pschorr反应-四氢-6,7-二甲氧基-2-甲基异喹啉(IIIn)给出异常产物1',2',3',4'-四氢-5,6,6',7,7'-五甲氧基-2'-甲基螺[indan-1,
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐